Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated Syndrome

dc.contributor.authorTrend, Stephanie
dc.contributor.authorJones, Anderson P
dc.contributor.authorCha, Lilian
dc.contributor.authorByrne, Scott N
dc.contributor.authorGeldenhuys, Sian
dc.contributor.authorFabis-Pedrini, Marzena J
dc.contributor.authorCarroll, William M
dc.contributor.authorCole, Judith M
dc.contributor.authorBooth, David R
dc.contributor.authorLucas, Robyn M
dc.contributor.authorKermode, Allan G
dc.contributor.authorFrench, Martyn A
dc.contributor.authorHart, Prue H
dc.date.accessioned2018-08-07T01:28:56Z
dc.date.available2018-08-07T01:28:56Z
dc.date.issued2018-07-13
dc.description.abstractClinically isolated syndrome (CIS) is a first episode of neurological symptoms that may precede a diagnosis of multiple sclerosis (MS). Therefore, studying individuals with CIS may lead to breakthroughs in understanding the development and pathogenesis of MS. In this study, serum levels of immunoglobulin (Ig)G, IgA, IgM, and IgG1-4 were measured in 20 people with CIS and compared with those in 10 healthy controls (HC) and 8 people with MS. Serum Ig levels in individuals with CIS were compared with (a) the time to their conversion from CIS to MS, (b) serum levels of antibodies to Epstein-Barr virus, (c) frequencies of T regulatory (Treg), T follicular regulatory (Tfr), and B cell subsets, and (d) Treg/Tfr expression of Helios. Serum IgG, IgM, and IgG2 levels were significantly lower in people with CIS than HC, and IgG, IgM, and IgG1 levels were significantly lower in people with CIS than MS. After adjusting for age, sex, and serum 25(OH) vitamin D3 [25(OH)D] levels, CIS was associated with lower serum levels of IgG and IgG2 compared with HC (p = 0.001 and p < 0.001, respectively). People with MS had lower IgG2 levels (p < 0.001) and IgG2 proportions (%IgG; p = 0.007) compared with HC. After adjusting for age, sex, and 25(OH)D, these outcomes remained, in addition to lower serum IgA levels (p = 0.01) and increased IgG3 levels (p = 0.053) in people with MS compared with HC. Furthermore, serum from people with MS had increased proportions of IgG1 and IgG3 (p = 0.03 and p = 0.02, respectively), decreased proportions of IgG2 (p = 0.007), and greater ratios of "upstream" to "downstream" IgG subclasses (p = 0.001) compared with HC. Serum IgG3 proportions (%IgG) from people with CIS correlated with the frequency of plasmablasts in peripheral blood (p = 0.02). Expression of Helios by Treg and Tfr cell subsets from individuals with CIS correlated with levels of serum IgG2 and IgG4. IgG3 levels and proportions of IgG3 (%IgG) in serum at CIS diagnosis were inversely correlated with the time until conversion to MS (p = 0.018 and p < 0.001, respectively), suggesting they may be useful prognostic markers of individuals with CIS who rapidly convert to MS.en_AU
dc.description.sponsorshipST, AJ, and MF-P are recipients of the Multiple Sclerosis Society of Western Australia (MSWA) Postdoctoral Research Fellowship. RL is a recipient of a National Health and Medical Research Council Senior Research Fellowship. This work is funded by a National Health and Medical Research Council Project Grant (ID 1067209).en_AU
dc.format13 pagesen_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn1664-3224en_AU
dc.identifier.urihttp://hdl.handle.net/1885/146099
dc.publisherFrontiers Mediaen_AU
dc.relationhttp://purl.org/au-research/grants/nhmrc/1067209en_AU
dc.rights© 2018 Trend, Jones, Cha, Byrne, Geldenhuys, Fabis-Pedrini, Carroll, Cole, Booth, Lucas, Kermode, French and Hart. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.en_AU
dc.sourceFrontiers in immunologyen_AU
dc.subjectantibodyen_AU
dc.subjectbiomarkersen_AU
dc.subjectclinically isolated syndromeen_AU
dc.subjectimmunoglobulinen_AU
dc.subjectmultiple sclerosisen_AU
dc.titleHigher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated Syndromeen_AU
dc.typeJournal articleen_AU
dcterms.accessRightsOpen Accessen_AU
dcterms.dateAccepted2018-06-27
local.bibliographicCitation.startpage1590en_AU
local.contributor.affiliationLucas, Robyn M., National Centre for Epidemiology & Population Health, CHM Research School of Population Health, The Australian National Universityen_AU
local.contributor.authoruidu4002313en_AU
local.identifier.ariespublicationu4492120xPUB236
local.identifier.citationvolume9en_AU
local.identifier.doi10.3389/fimmu.2018.01590en_AU
local.publisher.urlhttps://www.frontiersin.org/en_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01 Trend S et al Higher serum immunoglobulin 2018.pdf
Size:
343.57 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
884 B
Format:
Item-specific license agreed upon to submission
Description: